Institutional ticker directory tracking stock mentions, long/short ideas, and high-conviction pitches extracted from quarterly hedge fund letters.
| Ticker | Company | Sector | Industry | Pitches | Stance |
|---|---|---|---|---|---|
| Fund / Manager | Letter Commentary & Co-Mentions | Period / Date | Action |
|---|---|---|---|
“Amgen, the biopharmaceutical company, was one of the largest contributors during the quarter. The company has...” | Q3 2026 Oct 22, 2026 | Preview | |
“The Aristotle Value Equity Fund underperformed in Q4 2024 (-4.31% Class I-2 vs. -1.98% Russell 1000 Value Index) as narrow market momentum around artificial intelligence favored growth over value. Maintaining zero portfolio...” | Q4 2024 Dec 31, 2024 | Preview |
Read unredacted commentary excerpts, portfolio weight disclosures, and high-conviction theses from hedge fund managers discussing $AMGN.(33 additional institutional mentions locked).
Each excerpt above is the manager's commentary on this ticker specifically. The full letter has the rest of their portfolio thinking, risk discussion, and broader institutional context.